Skip to main content
Erschienen in: BMC Ophthalmology 1/2023

Open Access 01.12.2023 | Research

Hyperreflective material in patients with non-neovascular pachychoroid disease

verfasst von: Maiko Maruyama-Inoue, Yasuo Yanagi, Shaheeda Mohamed, Tatsuya Inoue, Yoko Kitajima, Shoko Ikeda, Kazuaki Kadonosono

Erschienen in: BMC Ophthalmology | Ausgabe 1/2023

Abstract

Background

This study aimed to report eleven cases of non-neovascular pachychoroid disease with hyperreflective material (HRM) that occurred in Japanese patients.

Methods

A retrospective review of data from eleven patients who had non-neovascular retinal pigment epithelium (RPE) protrusion with HRM in the neurosensory retina between March 2017 and June 2022 was conducted. Clinical examination, color fundus photography, fluorescein angiography, spectral-domain optical coherence tomography (SD-OCT), and OCT angiography data were analyzed. Main outcome measures were patient characteristics, changes in SD-OCT findings, and symptom outcomes.

Results

All cases had RPE protrusion and HRM with dilated choroidal veins, which were characteristic of pachychoroid disease. However, none of the cases had macular neovascularization (MNV). In 9 eyes (81.8%), HRM improved spontaneously without intervention and resulted in alterations in RPE, referred to as pachychoroid pigment epitheliopathy (PPE) or focal choroidal excavation (FCE). In these cases, symptoms such as metamorphopsia and distortion improved without treatment. In the remaining two cases (18.2%), HRM still persisted during the follow-up period.

Conclusion

There are some cases of non-neovascular pachychoroid disorder with HRM, which might be a new entity of pachychoroid spectrum disease or an early stage of PPE or FCE. These cases should not be misdiagnosed as MNV, and careful observation is necessary.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
OCT
Optical coherence tomography
OCTA
OCT angiography
ICGA
Indocyanine green angiography
MNV
Macular neovascularization
PPE
Pachychoroid pigment epitheliopathy
FCE
Focal choroidal excavation
CSC
Central serous chorioretinopathy
HRM
Hyperreflective material
RPE
Retinal pigment epithelium
SRF
Subretinal fluid 
SD-OCT
Spectral-domain OCT
FA
Fluorescein angiography
FAF
Fundus autofluorescence
CCT
Central choroidal thickness
BCVA
Best-corrected visual acuity
ICNV
Idiopathic choroidal neovascularization
AMD
Age-related macular degeneration
Log MAR
Logarithm of the minimum angle of resolution
ONL
Outer nuclear layer
OPL
Outer plexiform layer
VEGF
Vascular endothelial growth factor
SHRM
Subretinal hyperreflective material
HRF
Hyperreflective foci

Background

The development of optical coherence tomography (OCT) [1] and OCT angiography (OCTA) [2], which are novel noninvasive multimodal imaging modalities, has enabled the evaluation of the choroidal structure and morphology in patients with various chorioretinal diseases. Using these modalities, pachychoroid spectrum diseases, characterized by thick choroid, pachyvessels, attenuation of the inner choroid, and choroidal vascular hyperpermeability on indocyanine green angiography (ICGA), have been recently described [3]. Pachychoroid neovasculopathy [4] and polypoidal choroidal vasculopathy [5] are included in the pachychoroid-related spectrum of diseases associated with type 1 macular neovascularization (MNV). Furthermore, pachychoroid pigment epitheliopathy (PPE) [6], focal choroidal excavation (FCE) [7] and central serous chorioretinopathy (CSC) [8] also reside within the category of pachychoroid-related diseases with non-neovascular lesions. However, previous cases associated with non-neovascular pahychoroid disease showed no hyperreflective material (HRM) in the neurosensory retina.
Warrow et al. reported that PPE should be suspected in eyes with choroidal thickening and associated abnormalities of the retinal pigment epithelium (RPE) with neither history of subretinal fluid (SRF) nor type 1 MNV [6]. On the other hand, Jampol et al. firstly described that FCE is characterized by an unusual concavity in the choroid without staphyloma or scleral ectasia [9] and occurs in combined with other macular diseases such as CSC or MNV [10]. However, all cases reported in their articles had no HRM in the neurosensory retina. Recently, our group experienced cases of non-neovascular pachychoroid disease with HRM among relatively young Japanese patients, which finally resulted in PPE or FCE after the resolution of HRM. The purpose of this study is to put together these cases that describe that entity and provides a natural history for the HRM.

Methods

We conducted a retrospective review of the data of patients who had non-neovascular pachychoroid lesions with HRM in the neurosensory retina between March 2017 and June 2022. We studied eleven eyes of eleven patients in an observational case series. The patients were seen at Yokohama City University Medical Center after undergoing a prior evaluation by outside ophthalmologists, or were diagnosed by retina specialists (M.M. and Y.Y.) in a private clinic for metamorphopsia or visual complaints. This study design was approved by the institutional review board at Yokohama City University Medical Center and followed the tenets of the Declaration of Helsinki.
Inclusion criteria were the presence of non-neovascular pachychoroid lesions with HRM in the neurosensory retina determined by clinical findings and multimodal imaging. HRM were defined as hyper- or isoreflective exudation by using spectral-domain OCT (SD-OCT, SPECTRALIS OCT2 Multicolor version 6.12; Heidelberg Engineering Inc., Dossenheim, Germany and RS-3000 Advance; Nidek Co., Ltd., Aichi, Japan). SD-OCT system with built-in eye-tracking can provide reproducible measurements and we were able to evaluate the same location on OCT images at different time point [11]. Fluorescein angiography (FA), ICGA (SPECTRALIS Product Family version 5.3; Heidelberg Engineering, Inc.), fundus autofluorescence (FAF; Optos California®, Optos PLC, Dunfermline, UK), and OCTA (DRI OCT Triton; Topcon Corporation, Tokyo, Japan) were also used to evaluate the HRM lesions.
Central choroidal thickness (CCT) was measured in all eyes and was defined as the maximum thickness between the Bruch’s membrane and the inner surface of the choroidal–scleral junction at the fovea. Manual digital calipers were used to acquire these measurements. These cases were collected via a chart review, and data from these patients were reviewed. Changes in SD-OCT findings, changes of best-collected visual acuity (BCVA), and outcomes of the patients’ symptoms were investigated. Comparison of BCVA and CCT between baseline and last visit was performed using the Wilcoxon signed-rank test.

Results

We included a total of eleven eyes from eleven patients in this study. Table 1 shows the demographic and clinical characteristics of patients of non-neovascular pachychoroid disease with HRM in the neurosensory retina. Two of the eleven patients were given a diagnosis of idiopathic choroidal neovascularization (ICNV) or age-related macular degeneration (AMD) from their previous ophthalmologists, and two patients were referred for RPE changes in the macula. Of the eleven patients, eight (72.7%) were men and three (27.3%) were women. The mean patient age was 40.8 ± 10.7 years (median, 43 years; range, 23–60 years). The mean CCT was 307 ± 62 μm (range, 227–440 μm). All eleven eyes demonstrated pathologically dilated choroidal vessels (pachyvessels) on SD-OCT. The mean logarithm of the minimum angle of resolution (logMAR) BCVA was 0.062 (Snellen 20/23, range; 20/40 − 20/16). Representative cases of the patients are shown in Figs. 1, 2, 3, 4 and 5, respectively.
Table 1
Baseline characteristics and clinical data of the patients
Case
Patients
R/L
Age
Gender
Choroidal thickness(µm)
Best-corrected Visual Acuity
Final HRM
Location of HRM
Acoustic hyperreflectivity
PPE at final
FCE at final
Baseline
Last visit
Baseline
Last visit
1
1
L
47
M
349
324
20/30
20/20
improved
Subretina, ONL, OPL
+
+
-
2
2
R
44
M
268
299
20/16
20/16
improved
Subretina, ONL
-
-
-
3
3
R
36
F
305
290
20/25
20/16
improved
Subretina
-
+
-
4
4
R
43
M
314
316
20/32
20/40
improved
Subretina
+
+
-
5
5
L
30
M
253
263
20/20
20/20
improved
Subretina, ONL, OPL
+
-
+
6
6
R
60
M
351
362
20/25
20/25
persist
ONL, OPL
+
-
-
7
7
R
45
F
440
391
20/25
20/25
persist
Subretina, ONL, OPL
-
-
-
8
8
R
52
M
248
261
20/25
20/20
improved
Subretina
-
+
-
9
9
R
39
M
346
341
20/16
20/16
improved
Subretina
-
-
+
10
10
R
23
M
279
269
20/40
20/16
improved
Subretina, ONL
-
-
-
11
11
R
30
F
227
237
20/20
20/16
improved
Subretina
-
-
+
HRM Hyperreflective material, PPE Pachychoroid pigment epitheliopathy, FCE Focal choroidal excavation, ONL Outer nuclear layer, OPL Outer plexiform layer

Changes in SD-OCT findings

Of these 11 eyes, HRM at the subretinal space were present in 10 eyes (90.9%). There was presence of HRM at the outer nuclear layer (ONL) in 6 eyes (54.5%) and at the outer plexiform layer (OPL) in 4 eyes (36.4%). Among these 11 patients, 4 eyes (36.4%) had acoustic hyperreflectivity behind the HRM. In nine patients (81.8%), HRM improved spontaneously without intervention such as anti-vascular endothelial growth factor (VEGF) or anti-inflammatory therapy within 1 year. Four of nine (44.4%) eyes resulted in RPE alterations, which is referred to as PPE. Furthermore, three of nine eyes (33.3%) showed focal choroidal excavation (FCE) after the improvement of HRM. On the other hand, HRM persisted during the follow-up period in the remaining two eyes (18.2%). The mean CCT in last visit was 305 ± 47 μm, which was no significant difference compared with baseline (p = 0.929).

Symptom outcomes

The mean log MAR BCVA significantly improved from 0.062 to -0.001 (Snellen 20/19) (p = 0.046). Symptoms such as metamorphopsia or distortion also improved in nine eyes (81.8%) where the HRM ameliorated. On the other hand, the remaining two eyes (18.2%) with persistence of HRM showed no improvement of their symptoms.

Discussion

Our observational case series demonstrated that there are some cases of non-neovascular disease with HRM. All cases had thickened choroids and pachyvessels at a relatively young age. Furthermore, HRM improved spontaneously without intervention in nine eyes (81.8%) and finally resulted in so-called PPE or FCE. Although these cases are very rare in a real-world clinical setting, it could be a new entity of pachychoroid spectrum disease or an early stage of PPE or FCE. In addition, these cases might be misdiagnosed as AMD or ICNV because of the existence of HRM and suspected MNV. However, it is important that these cases should be diagnosed as non-neovascular disease using multimodal imaging and carefully observed without any intervention. To our knowledge, non-neovascular pachychoroid disorder with HRM reported in this study has not previously been described.
In the previous studies, HRM at the subretinal space were reported as subretinal hyperreflective material (SHRM). In the Comparison of Age-Related Macular degeneration Treatments Trials (CATT), SHRM was an important morphologic biomarker for worse visual acuity in patients with AMD [12]. SHRM is known to have several components, such as neovascular tissue, fibrosis, hemorrhage, and exudation, likely comprising serum, fibrin, and inflammatory cells [1315]. However, in our cases, it is deniable that HRM consists of neovascular tissue, fibrosis, or hemorrhage based on fundoscopic findings or multimodal imaging. Therefore, in this study, it is highly possible that HRM components were some kind of exudation. A previous study reported that in patients with CSC, which is categorized as one type of pachychoroid spectrum disease, breaches in the RPE could allow a large molecule, such as fibrin, to enter from the sub-RPE into the subretinal spaces [16]. Although the reason why patients in our study demonstrated HRM is uncertain, damage to the choriocapillaris, which was caused by the pachyvessels [17], would allow a large molecule such as fibrin to escape into the sub-RPE space. Furthermore, damage to the RPE would allow this molecule to enter from the sub-RPE to the subretinal spaces or neurosensory retina.
In our study, HRM were seen not only at the subretinal space but also at the OPL and ONL. Previous studies described that hyperreflective foci (HRF) [18], which is defined as hyperreflective speckling in the neurosensory retina detected by using SD-OCT, have been identified in various chorioretinal diseases [1921]. In this study, 4 eyes (case 1, 4, 5, and 6) had HRF, and these cases had acoustic hyperreflectivity behind the HRM. Proposed origin of HRF have several hypotheses, such as displacing RPE cells [18], activated microglia cells [22], and lipid extravasation [23]. Therefore, in some cases of this study, HRM might consist of these components.
In nine cases (81.8%), HRM improved spontaneously and four of them resulted in so-called PPE and three of them showed FCE. Symptoms such as metamorphopsia or distortion also improved in these eyes where the HRM ameliorated. Because both PPE and FCE are usually asymptomatic, we speculate that HRM was the cause of their symptoms. A previous study reported the morphologic characteristics of patients with CSC evaluated by SD-OCT [24]. Those authors described that SRF with subfoveal fibrin was more commonly observed in the early period of acute CSC than in eyes with chronic CSC. We speculate that having HRM indicates an active stage, and these characteristics disappear spontaneously when the activity declines. In addition, RPE alterations occur after improvement of HRM. Monés et al. described that some patients with soft drusen due to AMD showed isoreflective dots at the outer retinal layers associated with RPE defects. They have termed this ‘drusen ooze’, which was associated with a high risk of developing atrophy [25]. They hypothesized that drusen ooze could activate the surface of RPE, resulting in an increase in phagocytosis of extracellular debris that exceeds the RPE capacity, and finally leads to RPE death. Morphologic characteristics in our study are similar to that of their study. Therefore, HRM may activate the RPE apical surfaces, phagocytosed by RPE cells, and finally morphologic features might be similar to PPE.
Furthermore, three eyes (27.3%) showed FCE after the resolution of HRM. Although the pathogenesis of FCE formation is still uncertain, previous reports described that FCE lesions are congenital choroidal abnormalities [9, 26]. On the other hand, some reports mentioned that FCE may occur in associated with inflammatory diseases such as multiple evanescent white dot syndrome, multifocal choroiditis, or Vogt–Koyanagi–Harada disease [2729]. Similar to these cases, HRM in the neurosensory retina, due to inflammatory process, could be a mechanism leading to FCE formation. However, all cases in our study didn’t need anti-inflammatory therapy and improved spontaneously. Inflammation caused by HRM may be weak enough not to require treatment. Otherwise, it is a self-limited disorder.
In this study, the differential diagnosis was neovascular diseases, such as ICNV and AMD, because SHRM, which is derived from exudation, is generally associated with active MNV and often regresses as the MNV becomes quiescent after anti-VEGF treatment [14, 30]. However, all cases in this study had no MNV by multimodal imaging and were finally observed carefully without any intervention. Because the current optimal treatment for either ICNV or AMD is anti-VEGF agents [31, 32], it is important to check the existence of MNV by multimodal imaging and differentiate non-neovascular lesions with HRM from ICNV or AMD.
There are also some cases of non-neovascular pachychoroid lesion with HRM, which have SRF, as shown in Fig. 6. We speculate that the pathological mechanism of these cases are similar to our cases without SRF. However, these cases are now generally categorized as CSC due to SRF and photodynamic therapy might be taken into consideration for treatment [33].
The limitations of this study are the small sample size and its retrospective nature. Although these cases are very rare in the clinical setting, larger numbers of study subjects with detailed analysis are needed in the future. In addition, the evaluation of multimodal imaging could be reader dependent; to minimize this confounding factor, an AI machine system that includes machine-learning algorithms should be investigated. This could enable earlier detection of non-neovascular pachychoroid diseases and demonstrate there is no need for treatment.

Conclusions

We experienced eleven cases that had non-neovascular pachychoroid diseases with HRM. In addition, it is important to avoid a misdiagnosis of ICNV or AMD. It should be noted that non-neovascular pachychoroid diseases with HRM, occurring in relatively young adults, improve spontaneously without intervention.

Acknowledgements

None.

Declarations

The study was approved by the ethics committee of the Yokohama City University, Japan (approval number: F210900030) and written informed consent was obtained from all patients enrolled in this study.
Written informed consent was obtained. That is, the patient provided written, retrospective consent for publication following detailed explanation of the purpose of the manuscript and understanding that no identifiable information was going to be released.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.CrossRefPubMed Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.CrossRefPubMed
2.
Zurück zum Zitat Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50.CrossRefPubMed Spaide RF, Klancnik JM Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50.CrossRefPubMed
3.
Zurück zum Zitat Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33(1):14–33.CrossRefPubMed Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33(1):14–33.CrossRefPubMed
5.
Zurück zum Zitat Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M, Freund KB. Polypoidal Choroidal Vasculopathy: a distinct disease or manifestation of many? Retina. 2016;36(1):1–8.CrossRefPubMed Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M, Freund KB. Polypoidal Choroidal Vasculopathy: a distinct disease or manifestation of many? Retina. 2016;36(1):1–8.CrossRefPubMed
6.
Zurück zum Zitat Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33(8):1659–72.CrossRefPubMed Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33(8):1659–72.CrossRefPubMed
7.
Zurück zum Zitat Chung H, Byeon SH, Freund KB, Focal choroidal excavation and its association with pachychoroid spectrum disorders. A review of the literature and Multimodal Imaging Findings. Retina. 2017;37(2):199–221.CrossRefPubMed Chung H, Byeon SH, Freund KB, Focal choroidal excavation and its association with pachychoroid spectrum disorders. A review of the literature and Multimodal Imaging Findings. Retina. 2017;37(2):199–221.CrossRefPubMed
8.
Zurück zum Zitat Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32(9):1829–37.CrossRefPubMed Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32(9):1829–37.CrossRefPubMed
9.
Zurück zum Zitat Jampol LM, Shankle J, Schroeder R, Tornambe P, Spaide RF, Hee MR. Diagnostic and therapeutic challenges. Retina. 2006;26(9):1072–6.CrossRefPubMed Jampol LM, Shankle J, Schroeder R, Tornambe P, Spaide RF, Hee MR. Diagnostic and therapeutic challenges. Retina. 2006;26(9):1072–6.CrossRefPubMed
10.
Zurück zum Zitat Obata R, Takahashi H, Ueta T, Yuda K, Kure K, Yanagi Y. Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation. Retina. 2013;33(6):1201–10.CrossRefPubMed Obata R, Takahashi H, Ueta T, Yuda K, Kure K, Yanagi Y. Tomographic and angiographic characteristics of eyes with macular focal choroidal excavation. Retina. 2013;33(6):1201–10.CrossRefPubMed
11.
Zurück zum Zitat Menke MN, Dabov S, Knecht P, Sturm V. Reproducibility of retinal thickness measurements in healthy subjects using spectralis optical coherence tomography. Am J Ophthalmol. 2009;147(3):467–72.CrossRefPubMed Menke MN, Dabov S, Knecht P, Sturm V. Reproducibility of retinal thickness measurements in healthy subjects using spectralis optical coherence tomography. Am J Ophthalmol. 2009;147(3):467–72.CrossRefPubMed
12.
Zurück zum Zitat Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ. Comparison of age-related Macular Degeneration treatments trials Research G: Subretinal Hyperreflective Material in the comparison of age-related Macular Degeneration treatments trials. Ophthalmology. 2015;122(9):1846–1853e1845.CrossRefPubMed Willoughby AS, Ying GS, Toth CA, Maguire MG, Burns RE, Grunwald JE, Daniel E, Jaffe GJ. Comparison of age-related Macular Degeneration treatments trials Research G: Subretinal Hyperreflective Material in the comparison of age-related Macular Degeneration treatments trials. Ophthalmology. 2015;122(9):1846–1853e1845.CrossRefPubMed
13.
Zurück zum Zitat Ristau T, Keane PA, Walsh AC, Engin A, Mokwa N, Kirchhof B, Sadda SR, Liakopoulos S. Relationship between visual acuity and spectral domain optical coherence tomography retinal parameters in neovascular age-related macular degeneration. Ophthalmologica. 2014;231(1):37–44.CrossRefPubMed Ristau T, Keane PA, Walsh AC, Engin A, Mokwa N, Kirchhof B, Sadda SR, Liakopoulos S. Relationship between visual acuity and spectral domain optical coherence tomography retinal parameters in neovascular age-related macular degeneration. Ophthalmologica. 2014;231(1):37–44.CrossRefPubMed
14.
Zurück zum Zitat Ores R, Puche N, Querques G, Blanco-Garavito R, Merle B, Coscas G, Oubraham H, Semoun O, Souied EH. Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol. 2014;158(2):354–61.CrossRefPubMed Ores R, Puche N, Querques G, Blanco-Garavito R, Merle B, Coscas G, Oubraham H, Semoun O, Souied EH. Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol. 2014;158(2):354–61.CrossRefPubMed
15.
Zurück zum Zitat Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, et al. Consensus nomenclature for reporting neovascular age-related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration nomenclature Study Group. Ophthalmology. 2020;127(5):616–36.CrossRefPubMed Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, et al. Consensus nomenclature for reporting neovascular age-related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration nomenclature Study Group. Ophthalmology. 2020;127(5):616–36.CrossRefPubMed
16.
Zurück zum Zitat Rajesh B, Kaur A, Giridhar A, Gopalakrishnan M. Vacuole” sign adjacent to retinal pigment epithelial defects on Spectral Domain Optical Coherence Tomography in Central Serous Chorioretinopathy Associated with Subretinal Fibrin. Retina. 2017;37(2):316–24.CrossRefPubMed Rajesh B, Kaur A, Giridhar A, Gopalakrishnan M. Vacuole” sign adjacent to retinal pigment epithelial defects on Spectral Domain Optical Coherence Tomography in Central Serous Chorioretinopathy Associated with Subretinal Fibrin. Retina. 2017;37(2):316–24.CrossRefPubMed
17.
Zurück zum Zitat Baek J, Kook L, Lee WK. Choriocapillaris Flow Impairments in Association with Pachyvessel in Early Stages of Pachychoroid. Sci Rep. 2019;9(1):5565.CrossRefPubMedPubMedCentral Baek J, Kook L, Lee WK. Choriocapillaris Flow Impairments in Association with Pachyvessel in Early Stages of Pachychoroid. Sci Rep. 2019;9(1):5565.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology. 2009;116(3):488–496e482.CrossRefPubMed Schuman SG, Koreishi AF, Farsiu S, Jung SH, Izatt JA, Toth CA. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology. 2009;116(3):488–496e482.CrossRefPubMed
19.
Zurück zum Zitat Deak GG, Bolz M, Kriechbaum K, Prager S, Mylonas G, Scholda C, Schmidt-Erfurth U, Diabetic Retinopathy Research Group V. Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology. 2010;117(4):773–9.CrossRefPubMed Deak GG, Bolz M, Kriechbaum K, Prager S, Mylonas G, Scholda C, Schmidt-Erfurth U, Diabetic Retinopathy Research Group V. Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology. 2010;117(4):773–9.CrossRefPubMed
20.
Zurück zum Zitat Akagi-Kurashige Y, Tsujikawa A, Oishi A, Ooto S, Yamashiro K, Tamura H, Nakata I, Ueda-Arakawa N, Yoshimura N. Relationship between retinal morphological findings and visual function in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012;250(8):1129–36.CrossRefPubMed Akagi-Kurashige Y, Tsujikawa A, Oishi A, Ooto S, Yamashiro K, Tamura H, Nakata I, Ueda-Arakawa N, Yoshimura N. Relationship between retinal morphological findings and visual function in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2012;250(8):1129–36.CrossRefPubMed
21.
Zurück zum Zitat Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M, Yoshimura N. Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina. 2012;32(1):77–85.CrossRefPubMed Ogino K, Murakami T, Tsujikawa A, Miyamoto K, Sakamoto A, Ota M, Yoshimura N. Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion. Retina. 2012;32(1):77–85.CrossRefPubMed
22.
Zurück zum Zitat Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, Bandello F, Souied E. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2013;229(1):32–7.CrossRefPubMed Coscas G, De Benedetto U, Coscas F, Li Calzi CI, Vismara S, Roudot-Thoraval F, Bandello F, Souied E. Hyperreflective dots: a new spectral-domain optical coherence tomography entity for follow-up and prognosis in exudative age-related macular degeneration. Ophthalmologica. 2013;229(1):32–7.CrossRefPubMed
23.
Zurück zum Zitat Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C, Diabetic Retinopathy Research Group V. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914–20.CrossRefPubMed Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C, Diabetic Retinopathy Research Group V. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914–20.CrossRefPubMed
24.
Zurück zum Zitat Song IS, Shin YU, Lee BR. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;154(2):366–375e364.CrossRefPubMed Song IS, Shin YU, Lee BR. Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography. Am J Ophthalmol. 2012;154(2):366–375e364.CrossRefPubMed
25.
Zurück zum Zitat Mones J, Garcia M, Biarnes M, Lakkaraju A, Ferraro L. Drusen Ooze: a Novel Hypothesis in Geographic Atrophy. Ophthalmol Retina. 2017;1(6):461–73.CrossRefPubMed Mones J, Garcia M, Biarnes M, Lakkaraju A, Ferraro L. Drusen Ooze: a Novel Hypothesis in Geographic Atrophy. Ophthalmol Retina. 2017;1(6):461–73.CrossRefPubMed
26.
Zurück zum Zitat Margolis R, Mukkamala SK, Jampol LM, Spaide RF, Ober MD, Sorenson JA, Gentile RC, Miller JA, Sherman J, Freund KB. The expanded spectrum of focal choroidal excavation. Arch Ophthalmol. 2011;129(10):1320–5.CrossRefPubMed Margolis R, Mukkamala SK, Jampol LM, Spaide RF, Ober MD, Sorenson JA, Gentile RC, Miller JA, Sherman J, Freund KB. The expanded spectrum of focal choroidal excavation. Arch Ophthalmol. 2011;129(10):1320–5.CrossRefPubMed
27.
Zurück zum Zitat Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol. 2014;14:135.CrossRefPubMedPubMedCentral Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol. 2014;14:135.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Kim H, Woo SJ, Kim YK, Lee SC, Lee CS. Focal Choroidal Excavation in Multifocal Choroiditis and Punctate Inner Choroidopathy. Ophthalmology. 2015;122(7):1534–5.CrossRefPubMed Kim H, Woo SJ, Kim YK, Lee SC, Lee CS. Focal Choroidal Excavation in Multifocal Choroiditis and Punctate Inner Choroidopathy. Ophthalmology. 2015;122(7):1534–5.CrossRefPubMed
29.
Zurück zum Zitat Nishikawa Y, Fujinami K, Watanabe K, Noda T, Tsunoda K, Akiyama K. Clinical course of focal choroidal excavation in Vogt-Koyanagi-Harada disease. Clin Ophthalmol. 2014;8:2461–5.PubMedPubMedCentral Nishikawa Y, Fujinami K, Watanabe K, Noda T, Tsunoda K, Akiyama K. Clinical course of focal choroidal excavation in Vogt-Koyanagi-Harada disease. Clin Ophthalmol. 2014;8:2461–5.PubMedPubMedCentral
30.
Zurück zum Zitat Shah VP, Shah SA, Mrejen S, Freund KB. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina. 2014;34(7):1281–8.CrossRefPubMed Shah VP, Shah SA, Mrejen S, Freund KB. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration. Retina. 2014;34(7):1281–8.CrossRefPubMed
31.
Zurück zum Zitat Inoue M, Kadonosono K, Watanabe Y, Sato S, Kobayashi S, Yamane S, Ito R, Arakawa A. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Retina. 2010;30(5):733–8.CrossRefPubMed Inoue M, Kadonosono K, Watanabe Y, Sato S, Kobayashi S, Yamane S, Ito R, Arakawa A. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization. Retina. 2010;30(5):733–8.CrossRefPubMed
32.
Zurück zum Zitat Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.CrossRefPubMed Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419–31.CrossRefPubMed
33.
Zurück zum Zitat Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM Jr, Aizman A. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2003;23(3):288–98.CrossRefPubMed Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM Jr, Aizman A. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2003;23(3):288–98.CrossRefPubMed
Metadaten
Titel
Hyperreflective material in patients with non-neovascular pachychoroid disease
verfasst von
Maiko Maruyama-Inoue
Yasuo Yanagi
Shaheeda Mohamed
Tatsuya Inoue
Yoko Kitajima
Shoko Ikeda
Kazuaki Kadonosono
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2023
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-023-03011-2

Weitere Artikel der Ausgabe 1/2023

BMC Ophthalmology 1/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.